Revolution Medicines, Inc. (RVMD) /
The revenue of Revolution Medicines, Inc. over the past 8 years
Chart Revolution Medicines, Inc.: revenue, fiscal 2018–2025 Open the chart →Revolution Medicines, Inc. reported revenue of $0 in fiscal 2025, the latest fiscal year on file. In fiscal 2018 it was $20.16M. Year over year, revenue rose twice and fell 4 times. In these years the highest was $50.04M in fiscal 2019; the lowest $0 in fiscal 2024. The largest one-year move was in fiscal 2019: up 148%, from $20.16M to $50.04M.
Year by year
| Fiscal year | Revenue |
|---|---|
| 2025ended Dec 31, 2025 | $0 |
| 2024ended Dec 31, 2024 | $0 |
| 2023ended Dec 31, 2023 | $11.58M |
| 2022ended Dec 31, 2022 | $35.38M |
| 2021ended Dec 31, 2021 | $29.39M |
| 2020ended Dec 31, 2020 | $42.98M |
| 2019ended Dec 31, 2019 | $50.04M |
| 2018ended Dec 31, 2018 | $20.16M |
Fiscal years as Revolution Medicines, Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Revolution Medicines, Inc.
- The profitability of Revolution Medicines, Inc.
- The cash flow of Revolution Medicines, Inc.
- The debt of Revolution Medicines, Inc.
- All of Revolution Medicines, Inc.'s financials, charted
Companies of a similar size
- ELTHE ESTEE LAUDER COMPANIES INC.
- NBISNEBIUS GROUP N.V.
- PRUPRUDENTIAL FINANCIAL INC
- SYYSysco Corporation
- STMSTMicroelectronics N.V.
Not investment advice. This page shows what Revolution Medicines, Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.